IDEAS home Printed from https://ideas.repec.org/f/ppe847.html
   My authors  Follow this author

Lionel Perrier

Personal Details

First Name:Lionel
Middle Name:
Last Name:Perrier
Suffix:
RePEc Short-ID:ppe847
[This author has chosen not to make the email address public]
https://www.gate.cnrs.fr/spip.php?article40

Affiliation

Groupe d'Analyse et de Théorie Économique Lyon St-Étienne (GATE Lyon St-Étienne)
Université de Lyon

Lyon, France
http://www.gate.cnrs.fr/
RePEc:edi:gateefr (more details at EDIRC)

Research output

as
Jump to: Working papers Articles

Working papers

  1. Marina Touillaud & Baptiste Fournier & Olivia Pérol & Lidia Delrieu & Aurélia Maire & Elodie Belladame & David Pérol & Lionel Perrier & Marie Preau & Tanguy Leroy & Jean-Baptiste Fassier & Florie Fill, 2023. "Connected device and therapeutic patient education to promote physical activity among women with localised breast cancer (DISCO trial): protocol for a multicentre 2×2 factorial randomised controlled t," Post-Print halshs-03428061, HAL.
  2. Lionel Perrier & Wilfried Guets, 2021. "Determinants of the need for respite according to the characteristics of informal carers of elderly people at home: results from the 2015 French national survey," Post-Print halshs-03428062, HAL.
  3. François Gernier & Djihane Ahmed-Lecheheb & Patricia Pautier & Anne Floquet & Cédric Nadeau & Sophie Frank & Jérôme Alexandre & Frédéric Selle & Dominique Berton-Rigaud & Elsa Kalbacher & Hubert Orfeu, 2021. "“Chronic fatigue, quality of life and long-term side-effects of chemotherapy in patients treated for non-epithelial ovarian cancer: national case-control protocol study of the GINECO-Vivrovaire rare t," Post-Print halshs-03428068, HAL.
  4. Lionel Perrier, 2021. "Value based healthcare et donnée de vie réelles/SNDS en radiothérapie," Post-Print halshs-03428071, HAL.
  5. Véronique Raimond & Emmanuelle Kaltenbach & Christophe Adam & Sébastien Lazzarotto & Catherine Le Galès & Lionel Perrier & Jérôme Wittwer, 2021. "Challenges raised by the economic evaluation of CAR-T-cell therapies. The review by the French National Authority for Health," Post-Print halshs-03428067, HAL.
  6. Sébastien Thureau & Vincent Marchesi & Marie-Hélène Vieillard & Lionel Perrier & Albert Lisbona & Marianne Leheurteur & Jean Tredaniel & Stéphane Culine & Bernard Dubray & Naïma Bonnet & Bernard Assel, 2021. "Efficacy of extracranial stereotactic body radiation therapy (SBRT) added to standard treatment in patients with solid tumors (breast, prostate and non-small cell lung cancer) with up to 3 bone-only m," Post-Print halshs-03428060, HAL.
  7. Lionel Perrier & Marius Huguet & Véronique Raimond & Emmanuelle Kaltenbach & Vincent Augusto, 2021. "How much does the hospital stay for infusion of anti-CD19 CAR-T cells cost to the French National Health Insurance?," Post-Print halshs-03428065, HAL.
  8. Paul Giraud & Philippe Giraud & Eliot Nicolas & Pierre Boisselier & Marc Alfonsi & Michel Rives & Etienne Bardet & Valentin Calugaru & Georges Noel & Enrique Chajon & Pascal Pommier & Magali Morelle &, 2021. "Interpretable Machine Learning Model for Locoregional Relapse Prediction in Oropharyngeal Cancers," Post-Print halshs-03428057, HAL.
  9. Line Claude & Magali Morelle & Marc-André Mahé & David Pasquier & Pierre Boisselier & Pierre Yves Bondiau & Emmanuel Touboul & Karine Peignaux-Casasnovas & Isabelle Martel-Lafay & Frédéric Gassa & Lio, 2020. "A comparison of two modalities of stereotactic body radiation therapy for peripheral early-stage non-small cell lung cancer: results of a prospective French study," Post-Print halshs-03003498, HAL.
  10. Amina Amadou & Thomas Coudon & Delphine Praud & Pietro Salizzoni & Karen Leffondré & Emilie Lévêque & Marie-Christine Boutron-Ruault & Aurélie Danjou & Xavier Morelli & Charlotte Le Cornet & Lionel Pe, 2020. "Chronic Low-Dose Exposure to Xenoestrogen Ambient Air Pollutants and Breast Cancer Risk: XENAIR Protocol for a Case-Control Study Nested Within the French E3N Cohort," Post-Print halshs-03003523, HAL.
  11. Wilfried Guets & Hareth Al-Janabi & Lionel Perrier, 2020. "Cost–Utility Analyses of Interventions for Informal Carers: A Systematic and Critical Review," Post-Print halshs-02434688, HAL.
  12. Lionel Perrier & Aude-Marie Foucaut & Magali Morelle & Marina S. Touillaud & Anne-Sophie Kempf-Lépine & Dominik Heinz & Frédéric Gomez & Renaud Meyrand & Cédric Baudinet & Sophie Berthouze & Eric Reyn, 2020. "Cost-effectiveness of an exercise and nutritional intervention versus usual nutritional care during adjuvant treatment for localized breast cancer: the PASAPAS randomized controlled trial," Post-Print halshs-02378666, HAL.
  13. Mariam El Khal & Lionel Perrier & Julien Carretier & Marina Touillaud & Magalie Hureau & David Pérol & Béatrice Fervers, 2020. "Coût du programme d’éducation thérapeutique « Mieux manger, mieux bouger à l’aide de l’éducation nutritionnelle » chez les patientes atteintes d’un cancer du sein," Post-Print halshs-03428053, HAL.
  14. Séverine Coquerelle & Meryl Darlington & Morgane Michel & Manon Durand & Isabelle Borget & Sandrine Baffert & Patricia Marino & Lionel Perrier & Isabelle Durand-Zaleski, 2020. "Impact of Next Generation Sequencing on Clinical Practice in Oncology in France: Better Genetic Profiles for Patients Improve Access to Experimental Treatments," Post-Print halshs-02983051, HAL.
  15. Noémie Defourny & Lionel Perrier & Josep-Maria Borras & Mary Coffey & Julietta Corral & Sophie Hoozée & Judith Van Loon & Cai Grau & Yolande Lievens, 2019. "National costs and resource requirements of external beam radiotherapy: A time-driven activity-based costing model from the ESTRO-HERO project," Post-Print halshs-02378679, HAL.
  16. Lionel Perrier & Marius Huguet, 2019. "Impact d’une centralisation des soins en termes d’accès aux soins pour les cancers de l’ovaire et cancers du sein en France : une simulation à partir des données médico-administratives," Post-Print halshs-02378987, HAL.
  17. Bruno Laviolle & Olivier Perche & François Gueyffier & Élodie Bégué & Pascal Bilbault & Hélène Esperou & Florence Gaillard-Bigot & Guillaume Grenet & François Guérin & Caroline Guillot & Pierre-Henry , 2019. "Apport de la génomique dans la médecine de demain, applications cliniques et enjeux," Post-Print hal-02056433, HAL.
  18. Aude-Marie Foucaut & Magali Morelle & Anne-Sophie Kempf-Lépine & Cédric Baudinet & Renaud Meyrand & Séverine Guillemaut & Séverine Metzger & Valérie Bourne-Branchu & Elodie Grinand & Sylvie Chabaud & , 2019. "Feasibility of an exercise and nutritional intervention for weight management during adjuvant treatment for localized breast cancer: the PASAPAS randomized controlled trial," Post-Print halshs-02082772, HAL.
  19. Lionel Perrier, 2019. "Financial impact of innovation in Oncology," Post-Print halshs-02197096, HAL.
  20. Defourny Noémie & Monten Chris & Grau Cai & Lievens Yolande & Lionel Perrier, 2019. "Critical review and quality-assessment of cost analyses in radiotherapy: How reliable are the data?," Post-Print halshs-02378673, HAL.
  21. Wilfried Guets & Lionel Perrier & Hareth Al-Janabi, 2019. "Cost-utility analyses of interventions for informal caregivers: A systemic and critical review," Post-Print halshs-02379016, HAL.
  22. Lionel Perrier & Denis Koala & Marius Huguet & Magali Morelle & Vincent Augusto & Pierre Méeus & Françoise Ducimetière & Fadila Farsi & Isabelle Ray-Coquard, 2019. "Optimisation du parcours de soins dans la prise en charge initiale des cancers épithéliaux ovariens en France," Post-Print halshs-02197090, HAL.
  23. Lionel Perrier, 2019. "Impact financier de l’innovation en oncologie," Post-Print halshs-02194115, HAL.
  24. Patricia Marino & Rajae Touzani & Lionel Perrier & Etienne Rouleau & Dede Sika Kossi & Zou Zhaomin & Nathanaël Charrier & Nicolas Goardon & Claude Preudhomme & Isabelle Durand-Zaleski & Isabelle Borge, 2018. "Cost of cancer diagnosis using next-generation sequencing targeted gene panels in routine practice: a nationwide French study," Post-Print halshs-01703194, HAL.
  25. Olfa Rejeb & Claire Pilet & Sabri Hamana & Xie Xiaolan & Thierry Durand & Saber Aloui & Anne Doly & Pierre Biron & Lionel Perrier & Vincent Augusto, 2018. "Performance and cost evaluation of health information systems using micro-costing and discrete-event simulation," Post-Print halshs-01526704, HAL.
  26. Olivia Pérol & Barbara Charbotel & Lionel Perrier & Sandrine Bonnand & Elodie Belladame & Virginie Avrillon & Paul Rebattu & Frédéric Gomez & Géraldine Lauridant & Maurice Pérol & Béatrice Fervers, 2018. "Systematic Screening for Occupational Exposures in Lung Cancer Patients: A Prospective French Cohort," Post-Print halshs-01704517, HAL.
  27. Marius Huguet & Lionel Perrier & Olivia Bally & David Benayoun & Pierre de Saint Hilaire & Dominique Beal Ardisson & Magali Morelle & Nathalie Havet & Xavier Joutard & Pierre Méeus & Philippe Gabelle , 2018. "Being Treated In Higher Volume Hospitals Leads To Longer Progression-Free Survival For Epithelial Ovarian Carcinoma Patients in the Rhone-Alpes region of France," Post-Print halshs-01670155, HAL.
  28. Lionel Perrier & S. Baffert & A. Bertaux & J. Bonastre & N. Costa & F. Deniès & B. Dervaux & C. Dutot & P. Guerre & N. Havet & N. Hayes & A. Le Corroller-Soriano & C. Lejeune & B. Lueza & J. Margier &, 2018. "Éditorial," Post-Print halshs-01819359, HAL.
  29. Jean-Emmanuel Bibault & Magali Morelle & Marius Huguet & Lionel Perrier & Philippe Giraud, 2018. "In reply to Tallet et al," Post-Print halshs-01651499, HAL.
  30. Lionel Perrier, 2018. "Challenges in the value assessment, Pricing, and funding of targeted combination therapies in oncology," Post-Print halshs-02056546, HAL.
  31. Lionel Perrier & Pauline Rascle & Magali Morelle & Maud Toulmonde & Dominique Ranchere Vince & Axel Le Cesne & Philippe Terrier & Agnès Neuville & Pierre Méeus & Fadila Farsi & Françoise Ducimetière &, 2018. "The cost-saving effect of centralized histological reviews with soft tissue and visceral sarcomas, GIST, and desmoid tumors: The experiences of the pathologists of the French Sarcoma Group," Post-Print halshs-01784301, HAL.
  32. Jean-Emmanuel Bibault & Magali Morelle & Marius Huguet & Lionel Perrier & Philippe Giraud, 2018. "In reply to Jean-François Daisne, Sandra Nuyts, Fréderic Duprez and Benoît Bihin," Post-Print halshs-01651501, HAL.
  33. Morgane Plantier & Nathalie Havet & Thierry Durand & Nicolas Caquot & Camille Amaz & Irène Philip & Pierre Biron & Lionel Perrier, 2017. "Does adoption of electronic health records improve organizational performances of hospital surgical units? Results from the French e-SI (PREPS-SIPS) study," Post-Print halshs-01421101, HAL.
  34. Nathalie Havet & Alexis Penot & Magali Morelle & Lionel Perrier & Barbara Charbotel & Béatrice Fervers, 2017. "Trends in occupational disparities for exposure to carcinogenic, mutagenic and reprotoxic chemicals in France 2003–10," Post-Print halshs-01524444, HAL.
  35. Morgane Plantier & Nathalie Havet & Thierry Durand & Nicolas Caquot & Camille Amaz & Pierre Biron & Irène Philip & Lionel Perrier, 2017. "Does adoption of electronic health records improve the quality of care management in France? Results from the French e-SI (PREPS-SIPS) study," Post-Print halshs-01619178, HAL.
  36. Lionel Perrier, 2017. "Les impacts médico-économiques de l'évolution du parcours de soins en cancérologie," Post-Print halshs-01670547, HAL.
  37. Jean-Emmanuel Bibault & Sophie Dussart & Pascal Pommier & Magali Morelle & Marius Huguet & Pierre Boisselier & Bernard Coche-Dequeant & Marc Alfonsi & Etienne Bardet & Michel Rives & Valentin Calugaru, 2017. "Clinical Outcomes of Several IMRT Techniques for Patients With Head and Neck Cancer: A Propensity Score–Weighted Analysis," Post-Print halshs-01618896, HAL.
  38. Lionel Perrier, 2017. "Does adoption of electronic records improve organizational performances of hospital surgical units?," Post-Print halshs-01661999, HAL.
  39. Marius Huguet & Lionel Perrier & X Joutard & Isabelle Ray-Coquard, 2017. "What Underlies The Observed Hospital Volume-Outcome Relationship?," Post-Print halshs-01653405, HAL.
  40. Lionel Perrier, 2017. "Radiotherapy costs: the good, the bad and the ugly," Post-Print halshs-01527903, HAL.
  41. K. Gnep & T. Lizée & B. Campillo-Gimenez & G. Delpon & S. Droupy & Lionel Perrier & R. De Crevoisier, 2017. "Toxicité et qualité de vie comparées après curiethérapie par iode 125 et radiothérapie stéréotaxique des cancers prostatiques [Toxicity and quality of life comparison of iodine 125 brachytherapy and s," Post-Print hal-01618005, HAL.
  42. Lionel Perrier, 2017. "Does adoption of electronic heath record improve the quality of care management?," Post-Print halshs-01661998, HAL.
  43. Mathilde Penel-Page & Perrine Marec-Berard & Magali Morelle & Amandine Bertrand & Christèle Riberon & Helen Boyle & Lionel Perrier, 2017. "Management of Febrile Neutropenias in Adolescents and Young Adults: A Cost-Minimization Analysis Between Adult Versus Pediatric Units," Post-Print halshs-01618890, HAL.
  44. Lionel Perrier & Magali Morelle & Marius Huguet & Sophie Dussart & Philippe Giraud, 2017. "In Reply to Escande et al," Post-Print halshs-01421123, HAL.
  45. Sandrine Baffert & Julia Bonastre & Grégoire Mercier & Lionel Perrier, 2017. "Guide méthodologique sur le calcul et l’analyse des coûts hospitaliers," Post-Print halshs-01619444, HAL.
  46. Nathalie Havet & Alexis Penot & Magali Morelle & Lionel Perrier & Barbara Charbotel & Béatrice Fervers, 2017. "Varied exposure to carcinogenic, mutagenic, and reprotoxic (CMR) chemicals in occupational settings in France," Post-Print halshs-01446700, HAL.
  47. Antony Ceraulo & Antoine Ouziel & Emilie Lavergne & Lionel Perrier & Anne-Valérie Decouvelaere & Franck Chotel & Philippe Thiesse & Perrine Marec-Berard, 2017. "Percutaneous guided biopsy for diagnosing suspected primary malignant bone tumors in pediatric patients: a safe, accurate, and cost-saving procedure," Post-Print halshs-01421085, HAL.
  48. Lionel Perrier, 2017. "Analyse des corrélations entre informatisation et performance des établissements de santé," Post-Print halshs-01569065, HAL.
  49. Lionel Perrier & Noémie Defourny & Peter Dunscombe & Cai Grau & Yolande Lievens, 2017. "Cost of radiotherapy: what is the quality of the evidence found? Critical quality appraisal of studies estimating cost of radiotherapy," Post-Print halshs-01654668, HAL.
  50. Mélanie Varin & Barbara Charbotel & Olivia Pérol & Lionel Perrier & Amélie Massardier-Pilonchéry & Sandrine Bonnand & Elodie Belladame & Emmanuel Fort & Virginie Avrillon & Paul Rebattu & Maurice Péro, 2017. "Assessment of a self-administered questionnaire identifying occupational exposures among lung cancer patients [Évaluation d’un auto-questionnaire de repérage des expositions professionnelles chez l," Post-Print halshs-01526744, HAL.
  51. Aude-Marie Foucaut & Marina S. Touillaud & A. S. Kempf-Lépine & Magali Morelle & Dominik Heinz & Sophie Berthouze & Eric Reynes & Julien Carretier & S. Guillemaut & Sylvie Chabaud & V. Bourne-Branchu , 2016. "A cost-effectiveness analysis of a 6-month physical activity program versus usual dietary care during adjuvant chemotherapy in breast cancer: An economic evaluation of the PASAPAS trial," Post-Print halshs-01421080, HAL.
  52. Lionel Perrier & Morgane Plantier & Fadila Farsi & Patrick Vandenbergh & Hervé Spacagna & Frédéric Gomez & Pierre Biron & Thierry Durand, 2016. "Why should we focus on a structured model of secure digital exchanges to incorporate new documents in electronic patient records?," Post-Print halshs-01439348, HAL.
  53. Anne-Isabelle Poullié & Magali Cognet & Aline Gauthier & Marine Clementz & Sylvain Druais & Hans-Martin Späth & Lionel Perrier & Oliver Scemama & Catherine Rumeau Pichon & Jean-Luc Harousseau, 2016. "Cost-Effectiveness Of Treatments For Mild-To-Moderate Obstructive Sleep Apnea In France," Post-Print halshs-01327109, HAL.
  54. J-E Bibault & Magali Morelle & Lionel Perrier & Pascal Pommier & Pierre Boisselier & Bernard Coche-Dequeant & Olivier Gallocher & Marc Alfonsi & Etienne Bardet & Michel Rives & Valentin Calugaru & Enr, 2016. "Toxicity and efficacy of cetuximab associated with several modalitiesof IMRT for locally advanced head and neck cancer," Post-Print halshs-01366224, HAL.
  55. Lionel Perrier & Pascale Guerre, 2016. "Guide méthodologique sur le costing à l’Hôpital," Post-Print halshs-01500548, HAL.
  56. Maria-Laura Silva & John Paget & Anne Mosnier & Valérie Buthion & Jean Marie Cohen & Lionel Perrier & Hans-Martin Späth, 2016. "Development of Seasonal Influenza Vaccination Recommendations: Relevance and Influence of the Evidence on the Decision-Making Process in France and the Netherlands," Post-Print halshs-01366179, HAL.
  57. Lionel Perrier & Magali Morelle & Pascal Pommier & Pierre Boisselier & Bernard Coche-Dequeant & Olivier Gallocher & Marc Alfonsi & Etienne Bardet & Michel Rives & Valentin Calugaru & Enrique Chajon & , 2016. "A cost analysis of complex radiotherapy for patients with head and neck cancer," Post-Print halshs-01300834, HAL.
  58. Marius Huguet & Lionel Perrier & Olivia Ballyc & Xavier Joutard & Nathalie Havet & Fadila Farsi & David Benayoun & Pierre de Saint Hilaire & Dominique Beal Ardisson & Magali Morelle & LIsabelle Ray-Co, 2016. "Counterfactual approach with survival or time to event outcomes: An application to an exhaustive cohort of Epithelial Ovarian Carcinoma in the Rhône-Alps region of France," Working Papers 1622, Groupe d'Analyse et de Théorie Economique Lyon St-Étienne (GATE Lyon St-Étienne), Université de Lyon.
  59. Lionel Perrier & Magali Morelle & Sophie Dussart & Philippe Giraud, 2016. "In Reply to Fodor and Di Muzio," Post-Print halshs-01421125, HAL.
  60. Lionel Perrier & Morgane Plantier & Nathalie Havet & Thierry Durand & Nicolas Caquot & Camille Amaz & Pierre Biron & Irène Philip, 2016. "Dossier Patient Informatisé : quel impact sur la performance des établissements de santé en France ?," Post-Print halshs-01328996, HAL.
  61. Lionel Perrier & Morgane Plantier & Nathalie Havet & Thierry Durand & Nicolas Caquot & Camille Amaz & Pierre Biron & Irène Philip, 2016. "Système d'information et performance hospitalière," Post-Print halshs-01301932, HAL.
  62. Maria-Laura Silva & Lionel Perrier & John Paget & Anne Mosnier & Valérie Buthion & Jean Marie Cohen & Hans-Martin Späth, 2016. "Influenza vaccination policy-making processes in France and The Netherlands: Framework and determinants," Post-Print halshs-01266374, HAL.
  63. Dede Sika Kossi & Rajae Touzani & Isabelle Borget & Zhaomin Zou & Dominique Vaur & Etienne Rouleau & Claude Preudhomme & Lionel Perrier & Ludovic Lacroix & Isabelle Durand-Zaleski & Patricia Marino & , 2016. "Cost Analysis of Human Genome Sequencing in Cancer Diagnosis in France: Next Generation Sequencing," Post-Print halshs-01446644, HAL.
  64. Maria-Laura Silva & Lionel Perrier & Hans-Martin Späth & John Paget & Valérie Buthion & Anne Mosnier & Jean Marie Cohen & Marine Aulois-Griot, 2016. "General Practitioners Perceptions About Financial and Non-Financial Incentives to Improve Influenza Vaccination Coverage Rates In France," Post-Print halshs-01439558, HAL.
  65. Claire Pilet & Vincent Augusto & Sabri Hamana & Thierry Durand & Saber Aloui & Anne Doly & Pierre-Étienne Heudel & Laure Chauvenet & Maurice Pérol & Gilles Gonzalez & Pierre Biron & Lionel Perrier, 2016. "Is the Integrated Electronic Health Record Cost-Effective for a Cancer Consultation? Results from the E-SI (PREPS-SIPS) Study," Post-Print halshs-01439407, HAL.
  66. Noémie Defourny & Peter Dunscombe & Lionel Perrier & Cai Grau & Yolande Lievens, 2016. "Cost evaluations of radiotherapy: What do we know? An ESTRO-HERO analysis," Post-Print halshs-01421113, HAL.
  67. Lionel Perrier & Nathalie Havet & Irène Philip & Thierry Durand & Nicolas Caquot & Camille Amaz & Pierre Biron, 2016. "Impact of health information systems on hospital bed occupancy rates in French hospitals: results from the e-SI (PREPS-SIPS) study," Post-Print halshs-01421058, HAL.
  68. Carole Siani & Christian de Peretti & Julie A Vendrell & Balazs Gyorffy & Thomas Bachelot & Nicolas Plommet & Pascale Cohen & Lionel Perrier, 2016. "A cost-effectiveness analysis of the ZIRA test in breast cancer," Post-Print halshs-01366993, HAL.
  69. Lionel Perrier, 2015. "Relationship between the development of electronic health records and hospital accreditation decisions in France: results from the E-SI (Preps-Sips)," Post-Print halshs-01178650, HAL.
  70. Lionel Perrier & Nathalie Havet & Irène Philip & Thierry Durand & Nicolas Caquot & Camille Amaz & Pierre Biron, 2015. "Health Information System Adoption And Hospital Accreditation Decisions In France: Results From The E-SI (PREPS-SIPS) Study," Post-Print halshs-01193143, HAL.
  71. Morgane Plantier & Nathalie Havet & Nicolas Caquot & Pierre Biron & Camille Amaz & Thierry Durand & Irène Philip & Lionel Perrier, 2015. "Impact of Electronic Health Records on the Hospital Bed Occupancy Rates in Surgical Units in France: Results from the E-SI (PREPS-SIPS) Study," Post-Print halshs-01237556, HAL.
  72. Maria-Laura Silva & Lionel Perrier & Jean Marie Cohen & William John Paget & Anne Mosnier & Hans-Martin Späth, 2015. "A literature review to identify factors that determine policies for influenza vaccination," Post-Print halshs-01156520, HAL.
  73. Alessandra Buja & Diego Martines & Salvatore Lobello & Lionel Perrier, 2015. "A cost-consequence analysis of hepatitis B screening in an immigrant population," Post-Print halshs-01237025, HAL.
  74. Nathalie Havet & Alexis Penot & Magali Morelle & Lionel Perrier & Béatrice Fervers, 2014. "Inégalités de l'exposition aux produits cancérogènes, mutagènes ou reprotoxiques (CMR) en milieu professionnel en France," Post-Print halshs-01080555, HAL.
  75. Alexis Penot & Magali Morelle & Béatrice Fervers & Lionel Perrier, 2014. "Inégalités de l’exposition aux produits chimiques cancérogènes, mutagènes ou reprotoxiques (CMR) en milieu professionnel : les enseignements de l’enquête SUMER," Post-Print halshs-01076915, HAL.
  76. Lionel Perrier & Alessandra Buja & Giuseppe Mastrangelo & Patrick Sylvestre-Baron & Françoise Ducimetière & Peter Pauwels & Carlo Riccardo Rossi & François Noël Gilly & Amaury Martin & Bertrand Favier, 2014. "Transferability of health cost evaluation across locations in oncology: cluster and principal component analysis as an explorative tool," Post-Print halshs-01089763, HAL.
  77. Nathalie Havet & Alexis Penot & Magali Morelle & Lionel Perrier & Béatrice Fervers, 2014. "Inégalités d'exposition aux agents cancérogènes, mutagènes ou reprotoxiques (CMR) en milieu professionnel en France," Working Papers halshs-01098761, HAL.
  78. David G. Cox & Stéphane Ragusa & Lionel Pourteau & Lionel Perrier & Suzette Delaloge, 2014. "Cost-effectiveness of a Genetic Test for Breast Cancer Risk - Letter," Post-Print halshs-00957846, HAL.
  79. Nathalie Havet & Magali Morelle & Alexis Penot & Béatrice Fervers & Lionel Perrier, 2014. "Les fortes expositions aux produits cancérogènes, mutagènes ou reprotoxiques (CMR) sont-elles l'apanage des emplois précaires et peu qualifiés ?," Post-Print halshs-00954964, HAL.
  80. Nathalie Havet & Alexis Penot & Magali Morelle & Lionel Perrier & Béatrice Fervers, 2014. "Inégalités de l'exposition aux produits cancérogènes, mutagènes ou reprotoxiques (CMR) en milieu professionnel : les enseignements de l'enquête SUMER," Working Papers halshs-01080585, HAL.
  81. Lionel Perrier & Magali Morelle & Pascal Pommier, 2013. "Cost of prostate image-guided radiation therapy: Results of a randomized trial," Post-Print halshs-00799507, HAL.
  82. Magali Morelle & Lionel Perrier & Pascal Pommier & Frédéric Gomez & F. Millet-Lagarde & Didier Peiffert, 2013. "Curiethérapie : valorisation et aspects médico-économiques," Post-Print halshs-00862738, HAL.
  83. Maria-Laura Silva & Lionel Perrier & Jean Marie Cohen & Anne Mosnier & John Paget & Hans-Martin Späth, 2013. "Literature review of the decision-­‐making determinants related to the influenza vaccination policy," Working Papers halshs-00808536, HAL.
  84. Marina S. Touillaud & Aude-Marie Foucaut & Sophie Berthouze & Eric Reynes & A. S. Kempf-Lépine & Julien Carretier & David Pérol & S. Guillemaut & Sylvie Chabaud & V. Bourne-Branchu & Lionel Perrier & , 2013. "Design of a randomised controlled trial of adapted physical activity during adjuvant treatment for localised breast cancer: the PASAPAS feasibility study," Post-Print halshs-00940932, HAL.
  85. Lionel Perrier & Anne Lefranc & Philippe Quittet & Philippe Moreau & Carole Siani & Hervé Ghesquières & Fabrice Jardin & Bertrand Favier & Norbert Ifrah & Séverine Lissandre & David Pérol & Catherine , 2013. "Cost-effectiveness of Pegfilgrastim versus Filgrastim after high-dose chemotherapy and autologous stem cell transplantation in patients with lymphoma and myeloma," Post-Print halshs-00752571, HAL.
  86. Lionel Perrier, 2013. "Cost of physical activity intervention during adjuvant chemotherapy in breast cancer: results of the randomized trial PASAPAS," Post-Print halshs-00829582, HAL.
  87. Lionel Perrier, 2013. "A cost-analysis of stereotactic radiotherapy in lung cancer," Post-Print halshs-00952329, HAL.
  88. Lionel Perrier, 2013. "Comprendre les analyses médico-économiques : intervention didactique à l'intention des cliniciens," Post-Print halshs-00940941, HAL.
  89. Nathalie Havet & Magali Morelle & Alexis Penot & Béatrice Fervers & Lionel Perrier, 2013. "Inégalités de l'exposition aux produits cancérogènes, mutagènes ou reprotoxiques (CMR) en milieu professionnel : SUMER 2010," Post-Print halshs-00954966, HAL.
  90. Magali Morelle & Lionel Perrier & Pascal Pommier & Renaud de Crevoisier & Agnès Laplanche & Philippe Dudouet, 2012. "Evaluation économique prospective de la radiothérapie guidée par l'image des cancers de la prostate dans le cadre du programme national de Soutien aux Thérapeutiques Innovantes et Coûteuses," Post-Print halshs-00752616, HAL.
  91. Lionel Perrier & Alessandra Buja & Giuseppe Mastrangelo & Patrick Sylvestre-Baron & Petrus Pauwels & Carlo Rossi & François Gilly & Françoise Ducimetière & Bertrand Favier & Fadila Farsi & Mathieu Lar, 2012. "Cluster analysis and principal component analysis to access the variability of data in cost evaluations: methods and applications in oncology," Post-Print halshs-00752878, HAL.
  92. Catherine Sebban & Anne Lefranc & Lionel Perrier & Philippe Moreau & Daniel Espinouse & A. Schmidt & L. Kammoun & Hervé Ghesquières & C. Ferlay & Jacques-Olivier Bay & Séverine Lissandre & David Pérol, 2012. "A randomised phase II study of the efficacy, safety and cost-effectiveness of pegfilgrastim and filgrastim after autologous stem cell transplant for lymphoma and myeloma (PALM study)," Post-Print halshs-00680996, HAL.
  93. Lionel Perrier, 2012. "Cost-effectiveness analysis: an interdisciplinary research and methodological perspective," Post-Print halshs-00752916, HAL.
  94. Lionel Perrier & Dominique Ranchère-Vince & P. Terrier & A. Neuville & Anne-Valérie Decouvelaere & B. Bui & A. Le Cesne & Isabelle Ray-Coquard & Françoise Ducimetière & M. Jean-Denis & J.B. Courreges , 2012. "Discordant diagnoses in sarcoma, GIST and desmoide tumour in France: results from the network RREPS," Post-Print halshs-00752854, HAL.
  95. Nora Moumjid & Lionel Perrier & Maria-Laura Silva & Hans-Martin Späth, 2012. "The use of economic evaluations in health decision-making at the macro level: a literature review," Post-Print halshs-00752572, HAL.
  96. Maria-Laura Silva & Lionel Perrier & Hans-Martin Späth & Nathalie Havet & Jean Marie Cohen & Anne Mosnier, 2012. "Economic burden of seasonal influenza B in France during winter 2010-2011," Post-Print halshs-00954709, HAL.
  97. Lionel Perrier & Magali Morelle & Pascal Pommier & Jean-Léon Lagrange & Agnès Laplanche & Philippe Dudouet & Marc Mahé & Bruno Chauvet & Tan Dat Nguyen & Gilles Créhange & Angélique Duparc & Ayman Zaw, 2012. "A cost-analysis of image-guided radiation therapy (IGRT) in prostate cancer: results from a phase III clinical trial," Post-Print halshs-00752908, HAL.
  98. Lionel Perrier & Anne Lefranc & Philippe Quittet & Hervé Ghesquières & Bertrand Favier & Daniel Espinouse & Christian de Peretti & Marie Pierre Moles & Victoria Cacheux & Stéphane Leprêtre & Marc Rena, 2011. "Pegfilgrastim versus Filgrastim after high-dose chemotherapy and autologous stem cell transplantation in adult patients with lymphoma and myeloma: cost-effectiveness evaluation alongside a randomized ," Post-Print halshs-00628854, HAL.
  99. Lionel Perrier, 2011. "Conformity with clinical practice guidelines for management of patients with sarcoma: a cost-effectiveness assessment in two European regions," Post-Print halshs-00672132, HAL.
  100. Lionel Perrier, 2011. "Adherence to practice guidelines for the management of patients with sarcoma: A cost-effectiveness assessment in two European regions," Post-Print halshs-00672128, HAL.
  101. Lionel Perrier, 2011. "Apports de l'évaluation médico-économique pour la décision publique en santé," Post-Print halshs-00673319, HAL.
  102. Lionel Perrier, 2011. "Costi del tratamento," Post-Print halshs-00625404, HAL.
  103. Nathalie Havet & Magali Morelle & Lionel Perrier & Bertrand Favier & Frédéric Gomez & Anthony Montella & David Pérol & Paul Rebattu, 2010. "Impact of chemotherapy prescriptions and costs on survival in advanced or metastatic NSCLC: a single-institution study using an instrumental variables approach," Post-Print halshs-00667277, HAL.
  104. Lionel Perrier & Thierry Philip, 2010. "Apports de l'évaluation économique et de l'analyse d'impact budgétaire pour la décision publique en santé : l'exemple du cancer du sein," Post-Print halshs-00565785, HAL.
  105. Lionel Perrier, 2010. "Cost-effectiveness analysis: methods and applications in oncology," Post-Print halshs-00588784, HAL.
  106. Lionel Perrier, 2009. "Cost-effectiveness analysis of compliance with clinical guidelines for sarcoma management," Post-Print halshs-00451406, HAL.
  107. Lionel Perrier & Magali Morelle & Nathalie Havet & Anthony Montella & Bertrand Favier & David Pérol & Frédéric Gomez & Marie-Odile Carrère & Paul Rebattu, 2009. "The effect of health care expenditures on survival in locally advanced and metastatic Non Small Cell Lung Cancer," Post-Print halshs-00371825, HAL.
  108. Lionel Perrier & Pascal Pommier & Marie-Odile Carrère & Patrick Sylvestre-Baron, 2009. "Transférabilité des évaluations de coûts en santé : analyse des facteurs de variabilité," Post-Print halshs-00451617, HAL.
  109. Christophe Bergeron & Pierre Biron & Jean-Yves Blay & Nicola Cautela & Dominic Cellier & Guy de Laroche & Anne-Valérie Decouvelaere & Françoise Ducimetière & François Gilly & Nathalie Havet & Mathieu , 2009. "Costs and compliance with clinical practice guidelines: A pilot study for initial sarcoma treatment," Post-Print halshs-00954975, HAL.
  110. Lionel Perrier & Pascal Pommier & Marie-Odile Carrère & Patrick Sylvestre-Baron, 2008. "Les évaluations de coûts en santé sont-elles transférables ?," Post-Print halshs-00260873, HAL.
  111. Lionel Perrier & Nicola Cautela & Magali Morelle & Nathalie Havet & Françoise Ducimetière & Antoine Lurkin & Jean-Yves Blay & Pierre Biron & Dominique Ranchère-Vince & Anne-Valérie Decouvelaere & Phil, 2008. "Short-Term cost impact of compliance with clinical practice guidelines for initial sarcoma treatment," Post-Print halshs-00322614, HAL.
  112. Lionel Perrier & S.E. Combs & Thomas Auberger & Luciano Zucca & Ingemar Näslund & M. Pijls-Johannesma & J. Rochat & Y. Lievens & N'D. Gueye & Germaine Heeren & Pascal Pommier, 2008. "A Decision-making Tool for a Costly Innovative Technology: The Case of Carbon Ion Radiotherapy," Post-Print halshs-00353062, HAL.
  113. Lionel Perrier, 2007. "Organisation et financement des soins : vers une inadéquation croissante ?," Post-Print halshs-00267179, HAL.
  114. Marie-Odile Carrère & Lionel Perrier & Pascal Pommier & Patrick Sylvestre-Baron, 2007. "Assessing the generalisability of cost evaluation results using the euclidean metric and principal components analysis : Lesson from a high-cost innovation in oncology," Post-Print halshs-00266793, HAL.
  115. Lionel Perrier, 2007. "Les évaluations de coûts en santé sont-elles transférables ? Mesures et application à une innovation très coûteuse en cancérologie," Post-Print halshs-00267165, HAL.
  116. Magali Morelle & Lionel Perrier & Hervé Ghesquières & Catherine Sebban & Irène Philip & Jean-François Latour & Pierre Biron, 2007. "The impact of CD34+ cell dose on the cost of HDT with PBSC transplantation in lymphomia," Post-Print halshs-00159806, HAL.
  117. Lionel Perrier, 2006. "The contribution of the simulation for innovative technologies: The case of the hadrontherapy," Post-Print halshs-00267144, HAL.
  118. Lionel Perrier, 2005. "Report of work package 6 “Health economics aspects”," Post-Print halshs-00267137, HAL.
  119. Marie-Odile Carrère & Lionel Perrier & Pascal Pommier & J. Rochat & Luciano Zucca, 2005. "A model to calculate treatment cost per protocol for light ion facility radiotherapy projects in Europe," Post-Print halshs-00266174, HAL.
  120. Lionel Perrier & Thierry Philip, 2005. "Trajectoires optimales des patients évoluant vers la dépendance," Post-Print halshs-00157163, HAL.
  121. Pascal Pommier & Luciano Zucca & Ingemar Näslund & Thomas Auberger & Stephanie E. Combs & Guy François & Germaine Heeren & J. Rochat & Lionel Perrier, 2004. "Light ion facility projects in Europe: methodological aspects for the calculation of the treatment cost per protocol," Post-Print halshs-00156706, HAL.
  122. Lionel Perrier & Karima Nessah & Magali Morelle & Hervé Mignotte & Marie-Odile Carrère & Alain Brémond, 2004. "Cost comparison of two surgical strategies in the treatment of breast cancer: Sentinel lymph node biopsy versus axillary lymph node dissection," Post-Print halshs-00335472, HAL.
  123. Lionel Perrier & Catherine Sebban & Irène Philip & Baudouin Standaert & Magali Morelle & Jean-François Latour & Pierre Biron & Thierry Philip, 2002. "Vers une nécessaire harmonisation des évaluations de coûts en santé. L'exemple des intensifications thérapeutiques avec autogreffes de cellules souches du sang périphérique en France," Post-Print halshs-00335619, HAL.
  124. Béatrice Rey & Frédéric Chauvin & Lionel Perrier, 2001. "Les apports des concepts économiques "d'équipe" et de "groupe" pour l'évaluation des réseaux de soins," Post-Print halshs-03353413, HAL.

Articles

  1. Wilfried Guets & Hareth Al-Janabi & Lionel Perrier, 2020. "Cost–Utility Analyses of Interventions for Informal Carers: A Systematic and Critical Review," PharmacoEconomics, Springer, vol. 38(4), pages 341-356, April.
  2. Olfa Rejeb & Claire Pilet & Sabri Hamana & Xiaolan Xie & Thierry Durand & Saber Aloui & Anne Doly & Pierre Biron & Lionel Perrier & Vincent Augusto, 2018. "Performance and cost evaluation of health information systems using micro-costing and discrete-event simulation," Health Care Management Science, Springer, vol. 21(2), pages 204-223, June.
  3. Silva, Maria Laura & Perrier, Lionel & Paget, John W. & Mosnier, Anne & Buthion, Valérie & Cohen, Jean Marie & Späth, Hans Martin, 2016. "Influenza vaccination policy-making processes in France and The Netherlands: Framework and determinants," Health Policy, Elsevier, vol. 120(3), pages 293-305.
  4. Silva, Maria Laura & Perrier, Lionel & Cohen, Jean Marie & Paget, William John & Mosnier, Anne & Späth, Hans Martin, 2015. "A literature review to identify factors that determine policies for influenza vaccination," Health Policy, Elsevier, vol. 119(6), pages 697-708.
  5. Lionel Perrier & Anne Lefranc & David Pérol & Philippe Quittet & Aline Schmidt-Tanguy & Carole Siani & Christian Peretti & Bertrand Favier & Pierre Biron & Philippe Moreau & Jacques Bay & Séverine Lis, 2013. "Cost Effectiveness of Pegfilgrastim Versus Filgrastim After High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients with Lymphoma and Myeloma," Applied Health Economics and Health Policy, Springer, vol. 11(2), pages 129-138, April.
  6. Lionel Perrier & Pascal Pommier & Marie-Odile Carrère & Patrick Sylvestre-Baron, 2009. "Transférabilité des évaluations de coûts en santé. Analyse des facteurs de variabilité," Revue économique, Presses de Sciences-Po, vol. 60(2), pages 307-322.

Citations

Many of the citations below have been collected in an experimental project, CitEc, where a more detailed citation analysis can be found. These are citations from works listed in RePEc that could be analyzed mechanically. So far, only a minority of all works could be analyzed. See under "Corrections" how you can help improve the citation analysis.

Working papers

  1. Véronique Raimond & Emmanuelle Kaltenbach & Christophe Adam & Sébastien Lazzarotto & Catherine Le Galès & Lionel Perrier & Jérôme Wittwer, 2021. "Challenges raised by the economic evaluation of CAR-T-cell therapies. The review by the French National Authority for Health," Post-Print halshs-03428067, HAL.

    Cited by:

    1. Emanuela Foglia & Elisabetta Garagiola & Vito Ladisa & Alessandro Rambaldi & Roberto Cairoli & Simona Sammassimo & Emanuela Omodeo Salè & Pier Luigi Zinzani & Marco Esposti & Luisa Alberti & Maria Fra, 2023. "Multidimensional Results and Reflections on CAR-T: The Italian Evidence," IJERPH, MDPI, vol. 20(5), pages 1-17, February.

  2. Wilfried Guets & Hareth Al-Janabi & Lionel Perrier, 2020. "Cost–Utility Analyses of Interventions for Informal Carers: A Systematic and Critical Review," Post-Print halshs-02434688, HAL.

    Cited by:

    1. Nishit Dhanji & Werner Brouwer & Cam Donaldson & Eve Wittenberg & Hareth Al‐Janabi, 2021. "Estimating an exchange‐rate between care‐related and health‐related quality of life outcomes for economic evaluation: An application of the wellbeing valuation method," Health Economics, John Wiley & Sons, Ltd., vol. 30(11), pages 2847-2857, November.
    2. Wilfried Guets, 2021. "Does the formal home care provided to old-adults persons affect utilisation of support services by informal carers? An analysis of the French CARE and the U.S. NHATS/NSOC surveys," Working Papers halshs-03115306, HAL.
    3. Wilfried Guets, 2021. "Does the formal home care provided to old-adults persons affect utilisation of support services by informal carers? An analysis of the French CARE and the U.S. NHATS/NSOC surveys," Working Papers 2105, Groupe d'Analyse et de Théorie Economique Lyon St-Étienne (GATE Lyon St-Étienne), Université de Lyon.

  3. Lionel Perrier & Aude-Marie Foucaut & Magali Morelle & Marina S. Touillaud & Anne-Sophie Kempf-Lépine & Dominik Heinz & Frédéric Gomez & Renaud Meyrand & Cédric Baudinet & Sophie Berthouze & Eric Reyn, 2020. "Cost-effectiveness of an exercise and nutritional intervention versus usual nutritional care during adjuvant treatment for localized breast cancer: the PASAPAS randomized controlled trial," Post-Print halshs-02378666, HAL.

    Cited by:

    1. Louisa G. Gordon & Elizabeth G. Eakin & Rosalind R. Spence & Christopher Pyke & John Bashford & Christobel Saunders & Sandra C. Hayes, 2020. "Cost-Effectiveness Analysis from a Randomized Controlled Trial of Tailored Exercise Prescription for Women with Breast Cancer with 8-Year Follow-Up," IJERPH, MDPI, vol. 17(22), pages 1-13, November.

  4. Patricia Marino & Rajae Touzani & Lionel Perrier & Etienne Rouleau & Dede Sika Kossi & Zou Zhaomin & Nathanaël Charrier & Nicolas Goardon & Claude Preudhomme & Isabelle Durand-Zaleski & Isabelle Borge, 2018. "Cost of cancer diagnosis using next-generation sequencing targeted gene panels in routine practice: a nationwide French study," Post-Print halshs-01703194, HAL.

    Cited by:

    1. Séverine Coquerelle & Meryl Darlington & Morgane Michel & Manon Durand & Isabelle Borget & Sandrine Baffert & Patricia Marino & Lionel Perrier & Isabelle Durand-Zaleski, 2020. "Impact of Next Generation Sequencing on Clinical Practice in Oncology in France: Better Genetic Profiles for Patients Improve Access to Experimental Treatments," Post-Print halshs-02983051, HAL.

  5. Olfa Rejeb & Claire Pilet & Sabri Hamana & Xie Xiaolan & Thierry Durand & Saber Aloui & Anne Doly & Pierre Biron & Lionel Perrier & Vincent Augusto, 2018. "Performance and cost evaluation of health information systems using micro-costing and discrete-event simulation," Post-Print halshs-01526704, HAL.

    Cited by:

    1. Reda Lebcir & Usame Yakutcan & Eren Demir, 2022. "A decision support tool with health economic modelling for better management of DVT patients," Health Economics Review, Springer, vol. 12(1), pages 1-16, December.

  6. Olivia Pérol & Barbara Charbotel & Lionel Perrier & Sandrine Bonnand & Elodie Belladame & Virginie Avrillon & Paul Rebattu & Frédéric Gomez & Géraldine Lauridant & Maurice Pérol & Béatrice Fervers, 2018. "Systematic Screening for Occupational Exposures in Lung Cancer Patients: A Prospective French Cohort," Post-Print halshs-01704517, HAL.

    Cited by:

    1. Olivia Pérol & Nadège Lepage & Hugo Noelle & Pierre Lebailly & Benoit de Labrusse & Bénédicte Clin & Mathilde Boulanger & Delphine Praud & Françoise Fournié & Géraud Galvaing & Frédéric Dutheil & Brig, 2023. "A Multicenter Study to Assess a Systematic Screening of Occupational Exposures in Lung Cancer Patients," IJERPH, MDPI, vol. 20(6), pages 1-15, March.

  7. Marius Huguet & Lionel Perrier & Olivia Bally & David Benayoun & Pierre de Saint Hilaire & Dominique Beal Ardisson & Magali Morelle & Nathalie Havet & Xavier Joutard & Pierre Méeus & Philippe Gabelle , 2018. "Being Treated In Higher Volume Hospitals Leads To Longer Progression-Free Survival For Epithelial Ovarian Carcinoma Patients in the Rhone-Alpes region of France," Post-Print halshs-01670155, HAL.

    Cited by:

    1. Marius Huguet & Xavier Joutard & Isabelle Ray-Coquard & Lionel Perrier, 2022. "What underlies the observed hospital volume- outcome relationship?," Post-Print halshs-01801598, HAL.
    2. Marius Huguet & Xavier Joutard & Isabelle Ray-Coquard & Lionel Perrier, 2022. "What underlies the observed hospital volume- outcome relationship?," SciencePo Working papers Main halshs-01801598, HAL.
    3. Huguet, Marius, 2020. "Centralization of care in high volume hospitals and inequalities in access to care," Social Science & Medicine, Elsevier, vol. 260(C).

  8. Nathalie Havet & Alexis Penot & Magali Morelle & Lionel Perrier & Barbara Charbotel & Béatrice Fervers, 2017. "Trends in occupational disparities for exposure to carcinogenic, mutagenic and reprotoxic chemicals in France 2003–10," Post-Print halshs-01524444, HAL.

    Cited by:

    1. Nathalie Havet & Alexis Penot, 2022. "Collective Protection Measures for Occupational Exposure to Carcinogenic Chemicals in France: The Links between Regulations on Chemicals and Effective Implementation," IJERPH, MDPI, vol. 19(14), pages 1-13, July.

  9. Nathalie Havet & Alexis Penot & Magali Morelle & Lionel Perrier & Barbara Charbotel & Béatrice Fervers, 2017. "Varied exposure to carcinogenic, mutagenic, and reprotoxic (CMR) chemicals in occupational settings in France," Post-Print halshs-01446700, HAL.

    Cited by:

    1. Nathalie Havet & Alexis Penot, 2022. "Collective Protection Measures for Occupational Exposure to Carcinogenic Chemicals in France: The Links between Regulations on Chemicals and Effective Implementation," IJERPH, MDPI, vol. 19(14), pages 1-13, July.
    2. Luther Dogbla & Cédric Gouvenelle & Florence Thorin & François-Xavier Lesage & Marek Zak & Ukadike Chris Ugbolue & Barbara Charbotel & Julien S. Baker & Bruno Pereira & Frédéric Dutheil, 2023. "Occupational Risk Factors by Sectors: An Observational Study of 20,000 Workers," IJERPH, MDPI, vol. 20(4), pages 1-16, February.
    3. Nathalie Havet & J. Fournier & J. Stefanelli & M. Plantier & A. Penot, 2020. "Disparate exposure to physically demanding working conditions in France," Post-Print hal-03016411, HAL.
    4. Iffat Elbarazi & Sonia El-Zaemey & Basema Saddik & Balázs Ádám & Mohamed El Sadig & Aminu S. Abdullahi & Lin Fritschi & Mohamud Sheek-Hussein, 2022. "Estimate of Occupational Exposure to Carcinogens among Migrant Workers in the United Arab Emirates: A Cross-Sectional Study," IJERPH, MDPI, vol. 19(20), pages 1-12, October.
    5. Bénédicte La Rocca & Philippe Sarazin, 2022. "MiXie, an Online Tool for Better Health Assessment of Workers Exposed to Multiple Chemicals," IJERPH, MDPI, vol. 19(2), pages 1-11, January.

  10. Mélanie Varin & Barbara Charbotel & Olivia Pérol & Lionel Perrier & Amélie Massardier-Pilonchéry & Sandrine Bonnand & Elodie Belladame & Emmanuel Fort & Virginie Avrillon & Paul Rebattu & Maurice Péro, 2017. "Assessment of a self-administered questionnaire identifying occupational exposures among lung cancer patients [Évaluation d’un auto-questionnaire de repérage des expositions professionnelles chez l," Post-Print halshs-01526744, HAL.

    Cited by:

    1. Olivia Pérol & Barbara Charbotel & Lionel Perrier & Sandrine Bonnand & Elodie Belladame & Virginie Avrillon & Paul Rebattu & Frédéric Gomez & Géraldine Lauridant & Maurice Pérol & Beatrice Fervers, 2018. "Systematic Screening for Occupational Exposures in Lung Cancer Patients: A Prospective French Cohort," IJERPH, MDPI, vol. 15(1), pages 1-13, January.
    2. Olivia Pérol & Nadège Lepage & Hugo Noelle & Pierre Lebailly & Benoit de Labrusse & Bénédicte Clin & Mathilde Boulanger & Delphine Praud & Françoise Fournié & Géraud Galvaing & Frédéric Dutheil & Brig, 2023. "A Multicenter Study to Assess a Systematic Screening of Occupational Exposures in Lung Cancer Patients," IJERPH, MDPI, vol. 20(6), pages 1-15, March.

  11. Maria-Laura Silva & John Paget & Anne Mosnier & Valérie Buthion & Jean Marie Cohen & Lionel Perrier & Hans-Martin Späth, 2016. "Development of Seasonal Influenza Vaccination Recommendations: Relevance and Influence of the Evidence on the Decision-Making Process in France and the Netherlands," Post-Print halshs-01366179, HAL.

    Cited by:

    1. van der Putten, Ingeborg M. & Paulus, Aggie T.G. & Hiligsmann, Mickael & Hutubessy, Raymond C.W. & Evers, Silvia M.A.A., 2019. "Evidence-informed vaccine decision making: The introduction of Human Papilloma Virus (HPV) vaccination in the Netherlands," Health Policy, Elsevier, vol. 123(3), pages 260-266.

  12. Maria-Laura Silva & Lionel Perrier & John Paget & Anne Mosnier & Valérie Buthion & Jean Marie Cohen & Hans-Martin Späth, 2016. "Influenza vaccination policy-making processes in France and The Netherlands: Framework and determinants," Post-Print halshs-01266374, HAL.

    Cited by:

    1. Franco-Trigo, L. & Fernandez-Llimos, F. & Martínez-Martínez, F. & Benrimoj, S.I. & Sabater-Hernández, D., 2020. "Stakeholder analysis in health innovation planning processes: A systematic scoping review," Health Policy, Elsevier, vol. 124(10), pages 1083-1099.
    2. van der Putten, Ingeborg M. & Paulus, Aggie T.G. & Hiligsmann, Mickael & Hutubessy, Raymond C.W. & Evers, Silvia M.A.A., 2019. "Evidence-informed vaccine decision making: The introduction of Human Papilloma Virus (HPV) vaccination in the Netherlands," Health Policy, Elsevier, vol. 123(3), pages 260-266.

  13. Noémie Defourny & Peter Dunscombe & Lionel Perrier & Cai Grau & Yolande Lievens, 2016. "Cost evaluations of radiotherapy: What do we know? An ESTRO-HERO analysis," Post-Print halshs-01421113, HAL.

    Cited by:

    1. Mattia Altini & Laura Solinas & Lauro Bucchi & Nicola Gentili & Davide Gallegati & William Balzi & Fabio Falcini & Ilaria Massa, 2020. "Assessment of Cancer Care Costs in Disease-Specific Cancer Care Pathways," IJERPH, MDPI, vol. 17(13), pages 1-13, July.

  14. Maria-Laura Silva & Lionel Perrier & Jean Marie Cohen & William John Paget & Anne Mosnier & Hans-Martin Späth, 2015. "A literature review to identify factors that determine policies for influenza vaccination," Post-Print halshs-01156520, HAL.

    Cited by:

    1. Westerink-Duijzer, L.E. & van Jaarsveld, W.L. & Dekker, R., 2017. "Literature Review - the vaccine supply chain," Econometric Institute Research Papers EI2017-01, Erasmus University Rotterdam, Erasmus School of Economics (ESE), Econometric Institute.
    2. Silva, Maria Laura & Perrier, Lionel & Paget, John W. & Mosnier, Anne & Buthion, Valérie & Cohen, Jean Marie & Späth, Hans Martin, 2016. "Influenza vaccination policy-making processes in France and The Netherlands: Framework and determinants," Health Policy, Elsevier, vol. 120(3), pages 293-305.
    3. Westerink-Duijzer, L.E. & van Jaarsveld, W.L. & Dekker, R., 2017. "The benefits of combining early aspecific vaccination with later specific vaccination," Econometric Institute Research Papers EI2017-03, Erasmus University Rotterdam, Erasmus School of Economics (ESE), Econometric Institute.
    4. Shun-ichiro Bessho & Yoko Ibuka, 2016. "Vaccination policy of Japanese municipalities," Keio-IES Discussion Paper Series 2016-004, Institute for Economics Studies, Keio University.
    5. Shun‐ichiro Bessho & Yoko Ibuka, 2019. "Interdependency in vaccination policies among Japanese municipalities," Health Economics, John Wiley & Sons, Ltd., vol. 28(2), pages 299-310, February.

  15. Lionel Perrier & Magali Morelle & Pascal Pommier, 2013. "Cost of prostate image-guided radiation therapy: Results of a randomized trial," Post-Print halshs-00799507, HAL.

    Cited by:

    1. Neha Amin & David Sher & Andre Konski, 2014. "Systematic Review of the Cost Effectiveness of Radiation Therapy for Prostate Cancer from 2003 to 2013," Applied Health Economics and Health Policy, Springer, vol. 12(4), pages 391-408, August.

  16. Marina S. Touillaud & Aude-Marie Foucaut & Sophie Berthouze & Eric Reynes & A. S. Kempf-Lépine & Julien Carretier & David Pérol & S. Guillemaut & Sylvie Chabaud & V. Bourne-Branchu & Lionel Perrier & , 2013. "Design of a randomised controlled trial of adapted physical activity during adjuvant treatment for localised breast cancer: the PASAPAS feasibility study," Post-Print halshs-00940932, HAL.

    Cited by:

    1. Aude-Marie Foucaut & Sophie Berthouze & Marina Touillaud & Magali Morelle & Valérie Bourne-Branchu & Sophie Kempf-Lépine & Julien Carretier & David Pérol & Olivier Trédan & Patrick Bachmann & Béatrice, 2014. "Deterioration of Physical Activity Level and Metabolic Risk Factors After Early-Stage Breast Cancer Diagnosis," Post-Print hal-02128290, HAL.

  17. Catherine Sebban & Anne Lefranc & Lionel Perrier & Philippe Moreau & Daniel Espinouse & A. Schmidt & L. Kammoun & Hervé Ghesquières & C. Ferlay & Jacques-Olivier Bay & Séverine Lissandre & David Pérol, 2012. "A randomised phase II study of the efficacy, safety and cost-effectiveness of pegfilgrastim and filgrastim after autologous stem cell transplant for lymphoma and myeloma (PALM study)," Post-Print halshs-00680996, HAL.

    Cited by:

    1. Lionel Perrier & Anne Lefranc & Philippe Quittet & Philippe Moreau & Carole Siani & Hervé Ghesquières & Fabrice Jardin & Bertrand Favier & Norbert Ifrah & Séverine Lissandre & David Pérol & Catherine , 2011. "Cost-effectiveness of Pegfilgrastim versus Filgrastim after high-dose chemotherapy and autologous stem cell transplantation in patients with lymphoma and myeloma," Post-Print halshs-00628829, HAL.
    2. Simone Cesaro & Francesca Nesi & Gloria Tridello & Massimo Abate & Irene Sara Panizzolo & Rita Balter & Elisabetta Calore, 2013. "A Randomized, Non-Inferiority Study Comparing Efficacy and Safety of a Single Dose of Pegfilgrastim versus Daily Filgrastim in Pediatric Patients after Autologous Peripheral Blood Stem Cell Transplant," PLOS ONE, Public Library of Science, vol. 8(1), pages 1-8, January.

  18. Nora Moumjid & Lionel Perrier & Maria-Laura Silva & Hans-Martin Späth, 2012. "The use of economic evaluations in health decision-making at the macro level: a literature review," Post-Print halshs-00752572, HAL.

    Cited by:

    1. Persson, Emil & Tinghög, Gustav, 2020. "Opportunity cost neglect in public policy," Journal of Economic Behavior & Organization, Elsevier, vol. 170(C), pages 301-312.

Articles

  1. Wilfried Guets & Hareth Al-Janabi & Lionel Perrier, 2020. "Cost–Utility Analyses of Interventions for Informal Carers: A Systematic and Critical Review," PharmacoEconomics, Springer, vol. 38(4), pages 341-356, April.
    See citations under working paper version above.
  2. Olfa Rejeb & Claire Pilet & Sabri Hamana & Xiaolan Xie & Thierry Durand & Saber Aloui & Anne Doly & Pierre Biron & Lionel Perrier & Vincent Augusto, 2018. "Performance and cost evaluation of health information systems using micro-costing and discrete-event simulation," Health Care Management Science, Springer, vol. 21(2), pages 204-223, June.
    See citations under working paper version above.
  3. Silva, Maria Laura & Perrier, Lionel & Paget, John W. & Mosnier, Anne & Buthion, Valérie & Cohen, Jean Marie & Späth, Hans Martin, 2016. "Influenza vaccination policy-making processes in France and The Netherlands: Framework and determinants," Health Policy, Elsevier, vol. 120(3), pages 293-305.
    See citations under working paper version above.
  4. Silva, Maria Laura & Perrier, Lionel & Cohen, Jean Marie & Paget, William John & Mosnier, Anne & Späth, Hans Martin, 2015. "A literature review to identify factors that determine policies for influenza vaccination," Health Policy, Elsevier, vol. 119(6), pages 697-708.
    See citations under working paper version above.Sorry, no citations of articles recorded.

More information

Research fields, statistics, top rankings, if available.

Statistics

Access and download statistics for all items

Rankings

This author is among the top 5% authors according to these criteria:
  1. Number of Works
  2. Number of Distinct Works

Co-authorship network on CollEc

NEP Fields

NEP is an announcement service for new working papers, with a weekly report in each of many fields. This author has had 8 papers announced in NEP. These are the fields, ordered by number of announcements, along with their dates. If the author is listed in the directory of specialists for this field, a link is also provided.
  1. NEP-HEA: Health Economics (7) 2016-09-18 2016-10-16 2016-10-23 2018-04-02 2018-04-09 2018-06-11 2022-01-31. Author is listed
  2. NEP-CDM: Collective Decision-Making (1) 2013-04-20
  3. NEP-EUR: Microeconomic European Issues (1) 2018-06-11
  4. NEP-SOG: Sociology of Economics (1) 2016-09-18

Corrections

All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. For general information on how to correct material on RePEc, see these instructions.

To update listings or check citations waiting for approval, Lionel Perrier should log into the RePEc Author Service.

To make corrections to the bibliographic information of a particular item, find the technical contact on the abstract page of that item. There, details are also given on how to add or correct references and citations.

To link different versions of the same work, where versions have a different title, use this form. Note that if the versions have a very similar title and are in the author's profile, the links will usually be created automatically.

Please note that most corrections can take a couple of weeks to filter through the various RePEc services.

IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.